Menu
GeneBe

12-8604926-CAAAAAAAA-CAA

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP6_Moderate

The NM_020661.4(AICDA):​c.428-10_428-5del variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000008 in 1,249,680 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: not found (cov: 0)
Exomes 𝑓: 8.0e-7 ( 0 hom. )

Consequence

AICDA
NM_020661.4 splice_region, splice_polypyrimidine_tract, intron

Scores

Not classified

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 2.61
Variant links:
Genes affected
AICDA (HGNC:13203): (activation induced cytidine deaminase) This gene encodes a RNA-editing deaminase that is a member of the cytidine deaminase family. AICDA is specifically expressed and active in germinal center-like B cells. In the germinal center, AICDA is involved in somatic hypermutation, gene conversion, and class-switch recombination of immunoglobulin genes. An epigenetic role in neoplastic transformation and lymphoma progression has been experimentally ascribed to AICDA using mouse models. Defects in this gene are the cause of autosomal recessive hyper-IgM immunodeficiency syndrome type 2 (HIGM2). [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP6
Variant 12-8604926-CAAAAAA-C is Benign according to our data. Variant chr12-8604926-CAAAAAA-C is described in ClinVar as [Likely_benign]. Clinvar id is 1666461.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
AICDANM_020661.4 linkuse as main transcriptc.428-10_428-5del splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000229335.11
AICDANM_001330343.2 linkuse as main transcriptc.428-40_428-35del intron_variant
AICDANM_001410970.1 linkuse as main transcriptc.427+283_427+288del intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
AICDAENST00000229335.11 linkuse as main transcriptc.428-10_428-5del splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_020661.4 P1Q9GZX7-1

Frequencies

GnomAD3 genomes
Cov.:
0
GnomAD4 exome
AF:
8.00e-7
AC:
1
AN:
1249680
Hom.:
0
AF XY:
0.00000161
AC XY:
1
AN XY:
622912
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000104
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
0

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hyper-IgM syndrome type 2 Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeJul 19, 2022- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr12-8757522; API